Stay Informed

We Need You!

Advocating for a Treatment

The Galactosemia Foundation is urging the U.S. Food and Drug Administration (FDA) to incorporate the experiences and perspectives of people living with galactosemia in the agency’s review of govorestat (AT-007), the potential first-ever treatment for our rare genetic disease.

Latest News

Blog – February 4

Support the Galactosemia Foundation during Rare Disease Month

Read More

What to stay informed?

Check out our newsletters and sign up today!

Learn More

Funded Research

The Galactosemia Foundation provides funding for scientific and medical research related to the identification, treatment, and therapies related to classical galactosemia. The goal of this research initiative is to improve the lives of people with galactosemia.

Research In Progress

Many galactosemia research efforts are underway. Some of the studies are currently recruiting galactosemia community participants. Click on the information below to learn more about the various opportunities.